In the present study, we generated PTCH1−/− induced pluripotent stem cells (iPSCs) from NBCCS patient-derived iPSCs (PTCH1+/−) by gene editing. This evidence concerns the gene PTCH1 and nevoid basal cell carcinoma syndrome.